Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands |
3 Months Ended |
Nov. 30, 2021 |
Nov. 30, 2020 |
| Cash flows from operating activities: |
|
|
| Net income (loss) |
$ 451,943
|
$ 69,369
|
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: |
|
|
| Depreciation and amortization |
132,772
|
134,692
|
| Income (Loss) from Equity Method Investments, Net of Dividends or Distributions |
(140,387)
|
(40,842)
|
| Provision for doubtful accounts |
1,472
|
1,564
|
| Deferred taxes |
11,856
|
477
|
| Other, net |
(8,556)
|
(5,263)
|
| Changes in operating assets and liabilities, net of acquisitions: |
|
|
| Receivables |
(696,984)
|
(430,234)
|
| Inventories |
(1,274,141)
|
(967,637)
|
| Accounts payable and accrued expenses |
1,420,237
|
773,776
|
| Other liabilities |
(81,799)
|
(209,355)
|
| Net cash provided by (used in) operating activities |
(183,587)
|
(673,453)
|
| Cash flows from investing activities: |
|
|
| Acquisition of property, plant and equipment |
(74,878)
|
(85,680)
|
| Proceeds from disposition of property, plant and equipment |
2,822
|
3,350
|
| Expenditures for major repairs |
(5,541)
|
(6,313)
|
| Proceeds from Sales of Business, Affiliate and Productive Assets |
55,546
|
42,585
|
| Changes in CHS Capital notes receivable, net |
(31,509)
|
(79,045)
|
| Financing extended to customers |
(456)
|
(617)
|
| Payments from customer financing |
3,833
|
3,875
|
| Other investing activities, net |
(2,013)
|
7,534
|
| Net cash provided by (used in) investing activities |
(52,196)
|
(114,311)
|
| Cash flows from financing activities: |
|
|
| Proceeds from lines of credit and long-term borrowings |
4,952,834
|
6,620,876
|
| Payments on lines of credit, long-term borrowings and capital lease obligations |
(4,792,770)
|
(5,752,925)
|
| Preferred stock dividends paid |
(42,167)
|
(42,167)
|
| Redemptions of equities |
(12,221)
|
(7,726)
|
| Other financing activities, net |
50,326
|
(9,167)
|
| Net cash provided by (used in) financing activities |
156,002
|
808,891
|
| Effect of exchange rate changes on cash and cash equivalents |
(3,550)
|
2,324
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
(83,331)
|
23,451
|
| Cash and cash equivalents and restricted cash at beginning of period |
542,484
|
216,993
|
| Cash and cash equivalents and restricted cash at end of period |
$ 459,153
|
$ 240,444
|